Whereas, we found a significant decrease of BNIP3L/NIX and HIF-1α in C6-glioma and N2a cells after treatment with Cur and or SLCP (Figure 3F–I), whereas no significant changes were observed in the case of FUNDC1 protein in both the cell lines (Figure 3F,H). This evidence concerns the gene FUNDC1 and central nervous system cancer.